Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2012-03-05
Original market date: See footnote 1
2012-03-05
Product name:
ZELBORAF
Description:
FILM-COATED TABLET
DIN:
02380242
Product Monograph/Veterinary Labelling:
Date:
2019-12-10
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
HOFFMANN-LA ROCHE LIMITED
7070 Mississauga Road
Mississauga
Ontario
Canada
L5N 5M8
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
10:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
L01EC01 VEMURAFENIB
Active ingredient group (AIG) number:See footnote5
0153092001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| VEMURAFENIB | 240 MG |
Risk Management Plans See footnote 7
A Risk Management Plan (RMP) for this product was submitted.